Fundraising FoxSymeres
Netherlands, NL · 2 known investors
Find your way into Symeres
Sign up to see every warm intro you have to Symeres
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Symeres team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.
Founders & leadership
HS
Henning SteinhagenChief Executive Officer (CEO)Henning Steinhagen has spent 25 years in pharmaceutical and biotech R&D, serving as former President of R&D at Aptuit (acquired by Evotec AG in 2017) and co-founder and former CEO of Lario Therapeutics, a UK-based precision medicine company. He holds an executive MBA from IMD Lausanne and currently serves as CEO of Symeres.
Investors · 2
In the news
Frequently asked questions
- What does Symeres do?
- Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.
- Who are Symeres's investors?
- Symeres's investors include Gilde Healthcare, Keensight Capital.
- Where is Symeres headquartered?
- Symeres is headquartered in Netherlands, NL.